HP
Harvey Partners’s Harvard Bioscience HBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $950K | Sell |
2,141,099
-46,401
| -2% | -$20.6K | 0.09% | 41 |
|
|
2025
Q1 | $1.24M | Sell |
2,187,500
-495,500
| -18% | -$280K | 0.14% | 41 |
|
|
2024
Q4 | $5.66M | Sell |
2,683,000
-32,000
| -1% | -$67.5K | 0.63% | 38 |
|
|
2024
Q3 | $7.3M | Buy |
2,715,000
+157,500
| +6% | +$424K | 0.83% | 38 |
|
|
2024
Q2 | $7.29M | Hold |
2,557,500
| – | – | 0.88% | 34 |
|
|
2024
Q1 | $10.8M | Hold |
2,557,500
| – | – | 1.15% | 35 |
|
|
2023
Q4 | $13.7M | Hold |
2,557,500
| – | – | 1.55% | 30 |
|
|
2023
Q3 | $11M | Buy |
2,557,500
+33,500
| +1% | +$144K | 1.39% | 32 |
|
|
2023
Q2 | $13.9M | Sell |
2,524,000
-188,700
| -7% | -$1.04M | 1.69% | 31 |
|
|
2023
Q1 | $11.4M | Sell |
2,712,700
-198,800
| -7% | -$835K | 1.41% | 31 |
|
|
2022
Q4 | $8.06M | Buy |
2,911,500
+200
| +0% | +$554 | 1.02% | 33 |
|
|
2022
Q3 | $7.45M | Buy |
2,911,300
+46,300
| +2% | +$119K | 1.09% | 27 |
|
|
2022
Q2 | $10.3M | Buy |
2,865,000
+639,000
| +29% | +$2.3M | 2.27% | 22 |
|
|
2022
Q1 | $13.8M | Buy |
2,226,000
+961,000
| +76% | +$5.97M | 3.41% | 15 |
|
|
2021
Q4 | $8.92M | Buy |
1,265,000
+244,964
| +24% | +$1.73M | 3.62% | 9 |
|
|
2021
Q3 | $7.12M | Sell |
1,020,036
-79,964
| -7% | -$558K | 5.32% | 5 |
|
|
2021
Q2 | $9.16M | Hold |
1,100,000
| – | – | 6.35% | 2 |
|
|
2021
Q1 | $6.01M | Buy |
1,100,000
+107,000
| +11% | +$584K | 4.15% | 6 |
|
|
2020
Q4 | $4.26M | Buy |
993,000
+203,000
| +26% | +$871K | 2.96% | 9 |
|
|
2020
Q3 | $2.38M | Sell |
790,000
-35,500
| -4% | -$107K | 3.09% | 12 |
|
|
2020
Q2 | $2.56M | Sell |
825,500
-882,966
| -52% | -$2.74M | 3.09% | 10 |
|
|
2020
Q1 | $3.78M | Buy |
1,708,466
+696,765
| +69% | +$1.54M | 3.42% | 10 |
|
|
2019
Q4 | $3.09M | Buy |
1,011,701
+269,201
| +36% | +$821K | 1.75% | 20 |
|
|
2019
Q3 | $2.28M | Buy |
+742,500
| New | +$2.28M | 1.65% | 17 |
|